T1	Condition 27 34	allergy
T2	Condition 38 54	hypersensitivity
*	OR T1 T2
T3	Drug 58 66	tramadol
T4	Scope 27 54	allergy or hypersensitivity
R1	AND Arg1:T4 Arg2:T3	
T5	Condition 80 88	epilepsy
T6	Condition 92 103	convulsions
*	OR T5 T6
T7	Drug 141 156	analgesic drugs
T8	Drug 174 202	monoamine oxidase inhibitors
T9	Measurement 244 247	ICP
T10	Value 237 243	raised
R2	Has_value Arg1:T9 Arg2:T10	
T11	Condition 250 257	Obesity
T12	Person 259 264	women
T13	Measurement 272 287	body mass index
T14	Value 288 297	>35 kg/m2
T15	Person 301 304	men
T16	Measurement 312 327	body mass index
T17	Value 328 337	>42 kg/m2
R3	AND Arg1:T13 Arg2:T12	
R4	Has_value Arg1:T13 Arg2:T14	
R5	AND Arg1:T16 Arg2:T15	
R6	Has_value Arg1:T16 Arg2:T17	
*	OR T13 T16
T18	Scope 259 337	women with a body mass index >35 kg/m2 or men with a body mass index >42 kg/m2
R7	Has_scope Arg1:T11 Arg2:T18	
T19	Post-eligibility 340 356	Language barrier
T20	Drug 389 408	Ca channel blockers
T21	Drug 375 385	B-blockers
*	OR T21 T20
T22	Person 438 441	age
T23	Value 420 434	above 65 years
R8	Has_value Arg1:T22 Arg2:T23	
